The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
Use a concentration of 2 - 4 µg/ml. Detects a band of approximately 76 kDa (predicted molecular weight: 76 kDa).
Use a concentration of 20 µg/ml.
Use a concentration of 10 µg/ml.
FunctionInvolved in innate immunity against invading pathogens. Adapter used by TLR3 and TLR4 (through TICAM2) to mediate NF-kappa-B and interferon-regulatory factor (IRF) activation, and to induce apoptosis. Ligand binding to these receptors results in TRIF recruitment through its TIR domain. Distinct protein-interaction motifs allow recruitment of the effector proteins TBK1, TRAF6 and RIPK1, which in turn, lead to the activation of transcription factors IRF3 and IRF7, NF-kappa-B and FADD respectively.
Tissue specificityUbiquitously expressed but with higher levels in liver.
Sequence similaritiesContains 1 TIR domain.
DomainThe N-terminal region is essential for activation of the IFNB promoter activity.
Post-translational modificationsPhosphorylated by TBK1.
Immunofluorescence of TRIF in Human Lung cells using ab62583 at 10 ug/ml.
References for Anti-TRIF antibody (ab62583)
This product has been referenced in:
Banerjee S et al. TLR signaling-mediated differential histone modification at IL-10 and IL-12 promoter region leads to functional impairments in tumor-associated macrophages. Carcinogenesis : (2011).
Read more (PubMed: 21926109) »